Atorvastatin Gold-20 Clopidogrel & Aspirin Capsules

  • Product Name : Atorvastatin Gold-20 Clopidogrel & Aspirin Capsules
  • Category : Capsule
  • Manufacturer Name : Steris
  • Trade Name : Atovastrin Gold 20
  • Available Dosage : 20 mg
  • Packing : Strip
  • Pack Insert/Leaflet : 1 Pack/150 Capsules
  • Ingredients : Aspirin, Atorvastatin, Clopidogrel
  • Formulation : Capsule
  • Therapeutic use : for the prevention of heart attack
  • Production Capacity : 100000

Description:-

Introduction to Atorvastatin Gold-20 Clopidogrel & Aspirin Capsules

Atorvastatin Gold-20 Clopidogrel & Aspirin Capsules are a combination medication used for cardiovascular health. It contains three active ingredients: Atorvastatin (20 mg), Clopidogrel (75 mg), and Aspirin (75 mg).


Uses of Atorvastatin Gold-20 Clopidogrel & Aspirin Capsules

These capsules are primarily used for:

Cardiovascular Protection: Atorvastatin helps lower cholesterol levels, reducing the risk of heart attack and stroke.

Antiplatelet Activity: Clopidogrel and Aspirin prevent blood clot formation, reducing the risk of blood clot-related complications such as myocardial infarction and ischemic stroke.


Benefits of Atorvastatin Gold-20 Clopidogrel & Aspirin Capsules

Comprehensive Cardiovascular Care: Combines lipid-lowering (Atorvastatin), antiplatelet (Clopidogrel and Aspirin), and cardiovascular protective effects in one medication.

Reduced Cardiovascular Events: Lowers the risk of cardiovascular events by addressing multiple risk factors simultaneously.

Convenient Dosage: Provides a convenient once-daily dosing regimen for improved patient compliance.


Mechanism of Action of Atorvastatin Gold-20 Clopidogrel & Aspirin Capsules

Atorvastatin: Inhibits HMG-CoA reductase, an enzyme involved in cholesterol synthesis, thereby reducing LDL cholesterol levels and increasing HDL cholesterol levels.

Clopidogrel: Inhibits platelet aggregation by irreversibly binding to the P2Y12 receptor on platelets, preventing activation and subsequent clot formation.

Aspirin: Inhibits the enzyme cyclooxygenase, thereby reducing the production of thromboxane A2, a substance that promotes platelet aggregation.